Sign in

CIK 0001367083

  • Non-accelerated filer
  • Smaller reporting company

Sonoma Pharmaceuticals, Inc.

Sign in to watch
Ticker
SNOA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
680423298
Phone
+1 800-759-9305
Business address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
Former names
Oculus Innovative Sciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 86 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-08-24 Schutz James J Chief Operating Officer Grant or award · Stock Option (Right to Buy) +150,000 1,147,000
2012-08-24 Miller Robert E Chief Financial Officer Grant or award · Stock Option (Right to Buy) +150,000 852,064
2012-08-24 French Gregory M Director Grant or award · Stock Option (Right to Buy) +23,649 512,555
2012-08-24 Conley Richard K Director Grant or award · Stock Option (Right to Buy) +33,108 530,678
2012-08-24 Birnbaum Jay E Director Grant or award · Stock Option (Right to Buy) +23,649 328,649
2012-08-24 Alton Gregg H Director Grant or award · Stock Option (Right to Buy) +30,405 290,405
2012-03-07 Schutz James J Chief Operating Officer Grant or award · Stock Option (Right to Buy) +187,500 997,000
2012-03-07 Miller Robert E Chief Financial Officer Grant or award · Stock Option (Right to Buy) +62,500 702,064
2012-01-12 French Gregory M Director Grant or award · Stock Option (Right to Buy) +40,000 488,906

Page 13 of 13 · 249 trades